Professional Documents
Culture Documents
S
UICIDE IS A SIGNIFICANT PUBLIC
evidence of efficacy. Ascertaining which components of suicide prevention programs
health issue. In 2002, an esti- are effective in reducing rates of suicide and suicide attempt is essential in order to
mated 877 000 lives were lost optimize use of limited resources.
worldwide through suicide, rep- JAMA. 2005;294:2064-2074 www.jama.com
resenting 1.5% of the global burden of
disease or more than 20 million dis-
ability-adjusted life-years (years of cides per 100 000 persons. Latin Ameri- ing a huge human tragedy and an es-
healthy life lost through premature can and Muslim countries report the timated $11.8 billion in lost income.5
death or disability).1 The highest an- lowest rates, fewer than 6.5 per Suicidal behavior has multiple causes
nual rates are in Eastern Europe, where 100 000.2 In the United States, in 2002, that are broadly divided into proximal
10 countries report more than 27 sui- suicide accounted for 31 655 deaths, a
rate of 11.0 per 100 000 per year,3 and Author Affiliations are listed at the end of this article.
general population surveys document Corresponding Author: J. John Mann, MD, Depart-
CME available online at a suicide attempt rate of 0.6% and a sui- ment of Neuroscience, New York State Psychiatric In-
www.jama.com stitute, 1051 Riverside Dr, Box 42, New York, NY
cide ideation rate of 3.3%,4 represent- 10032 (jjm@columbia.edu).
2064 JAMA, October 26, 2005—Vol 294, No. 16 (Reprinted) ©2005 American Medical Association. All rights reserved.
stressors or triggers and predisposi- a primary care physician within a year Cochrane Library, and PsychINFO to
tion.6 Psychiatric illness is a major con- of their death and up to 66% within a identify reports evaluating suicide pre-
tributing factor, and more than 90% of month.17,18 Thus, a key prevention strat- vention interventions. An initial search
suicides have a Diagnostic and Statisti- egy is improved screening of de- used the MEDLINE identifier suicide (in-
cal Manual of Mental Disorders, Fourth pressed patients by primary care phy- cluding the subheading suicide, at-
Edition (DSM-IV) psychiatric ill- sicians and better treatment of major tempted) and the subheading prevention
ness,7-13 with some exceptions, such as depression. This review considers what and control, following that suicide was
in China.14 Mood disorders, princi- is known about this and other preven- combined with the following identifiers:
pally major depressive disorder and bi- tion strategies to permit integration into depression, health education, health pro-
polar disorder, are associated with about a comprehensive prevention strategy. motion, public opinion, mass screening,
60% of suicides.7,8,10,15,16 Other con- Suicide experts from 15 countries met family physicians, medical education, pri-
tributory factors include availability of in Salzburg, Austria, in August 2004 to mary health care, antidepressive agents,
lethal means, alcohol and drug abuse, review efficacy of suicide prevention in- psychotherapy, schools, adolescents, meth-
access to psychiatric treatment, atti- terventions. The 5-day workshop iden- ods, firearms, overdose, poisoning, gas poi-
tudes to suicide, help-seeking behav- tified 5 major areas of prevention: edu- soning, and mass media. We identified
ior, physical illness, marital status, age, cation and awareness programs for the 5020 articles, which were not bound by
and sex.6 To address these causes, sui- general public and professionals; screen- the 5 major areas identified during the
cide prevention involves a multifac- ing methods for high-risk persons; treat- workshop. Abstracts were reviewed and
eted approach with particular atten- ment of psychiatric disorders; restrict- full-text articles that met inclusion cri-
tion to mental health. The F IGURE ing access to lethal means; and media teria were retrieved. All reports were re-
illustrates the multiple factors in- reporting of suicide. viewed by at least 2 authors.
volved in suicidal behavior6 and indi-
cates where specific preventive inter- DATA SOURCES Study Selection
ventions are being directed. Suicide An electronic literature search of all ar- Studies were included if they reported on
prevention is possible because up to ticles published between 1966 and June either the primary outcomes of interest,
83% of suicides have had contact with 2005 was conducted via MEDLINE, the namely completed and attempted suicide
andsuicidalideation;or,whereapplicable,
Figure. Targets of Suicide Prevention Interventions
intermediate outcomes, including help-
seeking behavior, identification of at-risk
S U I C I D A L B E H AV I O R individuals, entry into treatment, and an-
A to E tidepressant prescription rates.
Mood or Other We included 3 major types of stud-
Stressful Life Event
Psychiatric Disorder
PREVENTION INTERVENTIONS ies for which the research question was
A Education and Awareness Programs clearly defined as assessment of efficacy
B Primary Care Physicians or effectiveness of prevention programs
General Public in terms of the above primary or second-
Suicidal Ideation Community or Organizational
Gatekeepers ary outcomes; (1) systematic reviews and
F A C T O R S I N V O LV E D B Screening for Individuals at High Risk
meta-analyses (n=10) for which the
I N S U I C I D A L B E H AV I O R search strategy was comprehensive and
C D Treatment the methodological quality of primary
Impulsivity C Pharmacotherapy studieswascriticallyappraised;(2)quan-
Antidepressants, Including Selective titative studies, either randomized con-
Serotonin Reuptake Inhibitors
C D
Antipsychotics
trolled trials (n=18), or cohort studies
Hopelessness
and/or Pessimism (n=24); and (3) ecological or popula-
D Psychotherapy
Alcoholism Programs
tion based studies (n=41). TABLE 1 and
F
Access to Cognitive Behavioral Therapy TABLE 2 detail study type, study popu-
Lethal Means lation, and preventive intervention tested
E Follow-up Care for Suicide Attempts and rate the studies according to the
G
F Restriction of Access to Lethal Means scheme proposed by the Oxford Centre
Imitation
for Evidence Based Medicine.112 Ran-
G Media Reporting Guidelines for Suicide
domized controlled trials provide the
most compelling evidence of efficacy
Suicidal Act while findings of naturalistic studies are
largely correlational, indicating that their
Circled letters refer to relevant prevention interventions listed on right. outcomes need further testing.
©2005 American Medical Association. All rights reserved. (Reprinted) JAMA, October 26, 2005—Vol 294, No. 16 2065
2066 JAMA, October 26, 2005—Vol 294, No. 16 (Reprinted) ©2005 American Medical Association. All rights reserved.
DATA SYNTHESIS preventing suicidal behavior.114 A sys- tion where education alone may be
Heterogeneity in study methodology tematic review of studies published insufficient.
and populations limited formal meta- from 1980-1995 found that knowl- A controlled trial comparing a treat-
analysis, thus we present a narrative edge about suicide improved but there ment algorithm plus depression care
synthesis of the results for the key do- were both beneficial and harmful effects management with treatment as usual for
mains of suicide prevention interven- in terms of help-seeking, attitudes, and late-life depression in primary care in the
tions. peer support.22 A later review of stud- United States demonstrated greater im-
ies published from 1990-2002 also provement in patient suicidal ideation
Awareness and Education found that curriculum-based pro- and a more favorable course of illness
General Public. Public education cam- grams increase knowledge and im- in the intervention group compared with
paigns are aimed at improving recog- prove attitudes to mental illness and sui- the treatment-as-usual group.31 An ado-
nition of suicide risk and help seeking cide but found insufficient evidence for lescent depression treatment quality im-
through improved understanding of the prevention of suicidal behavior.23 A sub- provement intervention with care man-
causes and risk factors for suicidal be- sequent controlled trial reported lower agers supporting primary care physicians
havior, particularly mental illness. Pub- suicide attempt rates, greater knowl- resulted in a 50% decrease in suicide at-
lic education also seeks to reduce stig- edge, and more adaptive attitudes about tempts in the intervention group that
matization of mental illness and suicide depression and suicide in the interven- was not statistically different from the
and challenges the acceptance of sui- tion group compared with in the 3 control group (18%) due to the low base
cide as inevitable, as a national char- months after the intervention, but no rate. 42 An Australian program that
acter trait, or as an appropriate solu- significant benefits for rates of suicide trained primary care physicians to rec-
tion to life problems, including serious ideation or help-seeking.29 In adoles- ognize and respond to psychological dis-
medical illness. Despite their popular- cents, several studies found that im- tress and suicidal ideation in young
ity as a public health intervention, the proving problem solving, coping with people increased identification of sui-
effectiveness of public awareness and stress, and increasing resilience en- cidal patients by 130% (determined by
education campaigns in reducing sui- hance hypothesized protective factors the Depressive Symptom Inventory–
cidal behavior has seldom been sys- but effects on suicidal behavior were un- Suicidality Subscale score), without
tematically evaluated. evaluated.43-45 changes in treatment or management
Studies in Germany,55 the United Primary Care Physicians. Depres- strategies.64 Studies examining suicidal
Kingdom,57 Australia,56 and New Zea- sion and other psychiatric disorders are behavior in response to primary care
land58 suggest modest effects of public underrecognized and undertreated in physician education programs, mostly
education campaigns on attitudes re- the primary care setting.116,117 Preven- targeting depression recognition and
garding the causes and treatment of de- tion is possible because most suicides treatment, in specific regions in Swe-
pression. Such public education and have had contact with a primary care den,66,118 Hungary,47 Japan,65 and Slov-
awareness campaigns, largely about de- physician within a month of death.17,18 enia48 have all reported increased pre-
pression, have no detectable effect on Primary care physicians’ lack of knowl- scription rate for antidepressants and
primary outcomes of decreasing sui- edge about or failure to screen pa- often substantial declines in suicide rates
cidal acts or on intermediate mea- tients for depression may contribute to and represent the most striking known
sures, such as more treatment seeking nontreatment seen in most suicides. example of a therapeutic intervention
or increased antidepressant use.57,58,113 Therefore, improving physician recog- lowering suicide rates.
The German study showed an 18% de- nition of depression and suicide risk Gatekeepers. Suicide prevention in-
crease in suicide attempts in an inter- evaluation is a component of suicide cludes a range of interventions focused
vention region after 9 months of a de- prevention. on community or organizational gate-
pression awareness campaign. 5 9 Some studies in the United King- keepers whose contact with potentially
However, the decline in suicide at- dom,61 Australia,60 the United States,24 vulnerable populations provides an op-
tempts occurred without a greater im- and Northern Ireland,49 showed that portunity to identify at-risk individu-
provement in attitudes in the interven- programs aimed at educating primary als and direct them to appropriate as-
tion region compared with the control care physicians improved detection and sessment and treatment.5 Gatekeepers
region.55 increased treatment of depression, but include clergy, first responders, phar-
Other specific education strategies that was not shown in other studies in macists, geriatric caregivers, personnel
are aimed at youth, including school the United States,62 Brazil,63 and the staff, and those employed in institu-
and community-based programs.114,115 United Kingdom.30 Nurse case man- tional settings, such as schools, pris-
Few such programs are evidence- agement, collaborative care, or quality ons, and the military. Education cov-
based, reflect the current state of knowl- improvement initiatives can further im- ered awareness of risk factors, policy
edge in suicide prevention, or evalu- prove the recognition and manage- changes to encourage help-seeking,
ate effectiveness and safety for ment of depression27 and has applica- availability of resources, and efforts to
©2005 American Medical Association. All rights reserved. (Reprinted) JAMA, October 26, 2005—Vol 294, No. 16 2067
reduce stigma associated with help- To date, systematic evaluation of im- Force52 have reported success in low-
seeking. In addition to gatekeeper train- pact on suicidal behavior has largely ering suicide rates.
ing, these programs also promoted or- been limited to multilevel programs
ganization-wide awareness of mental conducted in institutional settings, such Screening
health and suicide and facilitated ac- as the military where programs in the Screening aims to identify at-risk indi-
cess to mental health services. Norwegian Army 67 and the US Air viduals and direct them to treatment.
2068 JAMA, October 26, 2005—Vol 294, No. 16 (Reprinted) ©2005 American Medical Association. All rights reserved.
The focus may be on suicidal behavior orders.128 However meta-analyses of of untreated major depression and
directly or risk factors, such as depres- RCTs have generally not detected ben- therefore suicide.
sion or substance abuse. Screening in- efit for suicide or suicide attempts in Concerns about higher rates of sui-
struments for depression, suicidal ide- studies of antidepressants in mood and cide-related adverse event reports in de-
ation, or suicidal acts administered to other psychiatric disorders,19-21 per- pressed children and adolescents tak-
high school students,119 juvenile of- haps due to the low base rate of sui- ing selective serotonin reuptake
fenders,120 and youth in general121 have cidal behavior and insufficient system- inhibitors compared with placebo in
reliability and validity in identifying in- atic screening for suicidal behavior since RCTs have prompted regulatory bod-
dividuals at increased risk for suicidal reliance on spontaneous reporting un- ies in the United States, the United
behavior and are reported to double the derestimates rates of suicidal behav- Kingdom, and Europe to issue warn-
number of known at-risk individu- ior.129 Randomized controlled trials can ings urging clinicians to monitor sui-
als.122 There is no evidence that screen- be informative when higher-risk pa- cide risk and adverse effects carefully
ing youth for suicide induces suicidal tients are studied and indicate an an- when prescribing antidepressants to
thinking or behavior.123 Acceptance of tisuicidal effect for lithium in major youth. Such concerns need to be
the need for treatment by identified at- mood disorders 34 and clozapine in weighed against the risk of untreated
risk youth and actual treatment imple- schizophrenia.32,33 Few studies prospec- depression because suicide is the third
mentation are understudied as poten- tively identified suicidal behavior as an leading cause of death in youth and
tial barriers to the effectiveness of outcome measure and systematically as- more than 90% of suicides in de-
screening programs. sessed it throughout the RCT. pressed youth are untreated at the time
The US Preventive Services Task Higher prescription rates of antide- of death.130
Force (USPSTF) review of studies of de- pressants correlate with decreasing sui- Psychotherapy. Promising results in
pression screening in adults in pri- cide rates in adults or youth in Hun- reducing repetition of suicidal behav-
mary health care settings found a 10% gary,47 Sweden,89 Australia,93 and the ior and improving treatment adher-
to 47% increase in rates of detection and United States.91,92 Geographic regions ence exist for cognitive therapy,35 prob-
diagnosis of depression with the use of or demographic groups with the high- lem-solving therapy,28 intensive care
screening tools.24 The effect on treat- est selective serotonin reuptake inhibi- plus outreach,28 and interpersonal psy-
ment was mixed, due to differences in tor prescription rates have the lowest chotherapy,36 compared with standard
study methodology. In contrast, a Ca- suicide rates in the United States91 and aftercare. Cognitive therapy halved the
nadian review of depression screening Australia. 93 Although Iceland, 94 Ja- reattempt rate in suicide attempters
studies did not find routine screening pan,95 and Italy96 do not show such cor- compared with those receiving usual
in primary care to improve depression relations, potential reasons include lack care.35 In borderline personality disor-
care.25 Neither report commented on of compliance; pre-existing low- der, dialectical behavioral therapy28 and
effects on suicidal behavior. In con- suicide rate, resulting in a floor effect; psychoanalytically oriented partial hos-
trast, screening in localized geo- and high rates of alcoholism that may pitalization37 improved treatment ad-
graphic areas results in more treat- elevate suicide rates or the effect may herence and reduced suicidal behav-
ment of depression and lower suicide be confined to women because too few ior compared with standard after care.
rates. 50,51,66 The 2004 USPSTF 26 re- men seek and comply with treatment Intermediate outcomes such as hope-
view of evidence on screening for sui- with antidepressants. Suicide rates in lessness and depressive symptoms im-
cide risk, as opposed to depression, 27 countries fell most markedly in prove with problem solving therapy, and
found no published studies in English countries that had the greatest in- suicidal ideation is decreased with in-
evaluating the effectiveness of screen- crease in selective serotonin reuptake terpersonal psychotherapy, cognitive be-
ing for suicide risk in primary care. inhibitor prescriptions.99 Patient popu- havior therapy, and dialectical behav-
lation studies report lower suicide at- ioral therapy.26
Treatment Interventions tempt rates in adults treated with an- Follow-up Care After Suicide
Pharmacotherapy. Psychiatric disor- tidepressant medication 9 7 and in Attempts. Many psychiatric disor-
ders are present in at least 90% of sui- adolescents after 6 months of antide- ders, including depression, are chronic
cides and more than 80% are un- pressant treatment compared with less and recurrent131 and compliance with
treated at time of death.124,125 Depression than two months of treatment.98 The maintenance medication is often poor.
is untreated or undertreated in gen- risk of an ecological fallacy, that is, in- Interventions for depression provided
eral, 1 1 6 , 1 2 6 even after suicide at- ferring causality from group correla- by primary care physicians are more ef-
tempt.127 Thus, treating mood and other tions, prevents attributing decreases in fective when a case manager follows up
psychiatric disorders is a central com- suicide rates solely to antidepressant with patients who miss appointments
ponent of suicide prevention.5 use. Nevertheless, there is a striking cor- or need prescription renewals.132 Many
Antidepressant medications allevi- relation and plausible mechanism link- depressed patients who survive a sui-
ate depression and other psychiatric dis- ing antidepressant use to declining rates cide attempt will make further suicide
©2005 American Medical Association. All rights reserved. (Reprinted) JAMA, October 26, 2005—Vol 294, No. 16 2069
Physician Education. This in- high school and college student popu- of Medicine and Health Sciences, Christchurch, New
Zealand (Dr Beautrais); American Foundation for Sui-
creases the number of diagnosed and lations, further consideration needs to cide Prevention, New York, NY (Drs Haas and Hen-
treated depressed patients with accom- be given to determining the cost- din); Department of Psychiatry, Ludwig-Maximilians-
Universität, Munich, Germany (Dr Hegerl); Department
panying reductions in suicide al- effectiveness of screening general popu- of Mental Health and Alcohol Research, National Pub-
though booster programs appear nec- lations vs identified at-risk popula- lic Health Institute, Helsinki, Finland (Dr Lonnqvist);
essary. Videoconferencing and other tions for reducing suicide rates, the Department of Psychiatry & Mental Health Re-
search, St Vincents University Hospital, Dublin, Ire-
teleconferencing consulting methods predictive validity and reliability of spe- land (Dr Malone); Institute of Public Health of the Re-
are possibilities where expert help is not cific screening instruments, and the ap- public of Slovenia, Ljubjana, Slovenia (Dr Marusic);
Suicide Research and Prevention Unit, University of
available locally. However, the effect on propriateness of standard suicide Oslo, Oslo, Norway (Dr Mehlum); Centre for Ado-
suicide rates must be measured, as well screening instruments across different lescent Health, University of Melbourne, Melbourne,
Australia (Dr Patton); Beijing Suicide Research and Pre-
as effects on intermediate outcomes, cultures. vention Center, Beijing, China (Dr Phillips); Division
such as primary care physician– Psychotherapy. Psychotherapy alone of Psychiatry, Unit for Social Psychiatry and Health Pro-
motion, Academic University Hospital, Uppsala, Swe-
diagnosed cases of major depression or in combination with some antide- den (Dr Rutz); National Institute for Psychiatry and
and antidepressant prescription rates. pressants can be an effective treat- Neurology, Budapest, Hungary (Dr Rihmer); Depart-
Pharmacotherapy. Randomized con- ment for depression, for suicidal ide- ment of Psychiatry and Psychotherapy, University of
Würzburg, Würzburg, Germany (Dr Schmidtke); Na-
trolled trials are needed to prove that ation, for suicide attempts in borderline tional Suicide Prevention Technical Resource Center,
selective serotonin reuptake inhibi- personality disorder, and for prevent- Centers for Disease Prevention and Control, New-
ton, Mass (Dr Silverman); Division of Behavior Sci-
tors decrease suicide rates. Their effi- ing new attempts after a suicide at- ences, National Defense Medical College Research
cacy is established for major depres- tempt. More needs to be known about Institute, Tokyo, Japan (Dr Takahashi); Estonian-
Swedish Suicidology Institute, Center Behavior and
sion, the main risk factor for suicide. the combinations of psychotherapeu- Health Science, Tallinn, Estonia (Dr Varnik); Depart-
Education programs targeting pri- tic and pharmacologic interventions for ment of Public Health Sciences at Karolinska Insti-
mary care physicians should include in- short-and long-term outcomes for sui- tute, Swedish National Centre for Suicide Research and
Prevention of Mental Ill-Health, Stockholm, Sweden
struction on use of antidepressants. The cidal patients. (Dr Wasserman); and Hong Kong Jockey Club Cen-
relationship between antidepressant use Chain of Care. After a suicide at- ter for Suicide Research and Prevention, University of
Hong Kong, Hong Kong, China (Dr Yip).
and emergent suicidal ideation and be- tempt, better structured collaboration Author Contributions: Dr Mann had full access to all
havior in depressed children and ado- between hospitals and teams provid- of the data in the study and takes responsibility for
the integrity of the data and the accuracy of the data
lescents needs further study. Because ing follow-up care may improve com- analysis.
most depressed youth who attempt sui- pliance with treatment and decrease Study concept and design: Mann, Apter, Beautrais,
Haas, Hegerl, Lonnqvist, Malone, Mehlum, Schmidtke,
cide are untreated, it is important not new attempts, but essential elements of Shaffer, Varnik, Wasserman, Yip, Hendin.
to prematurely discourage the use of ef- postsuicide attempt interventions are Acquisition of data: Mann, Apter, Bertolote, Hegerl,
fective antidepressants such as fluox- yet to be identified. Lonnqvist, Malone, Marusic, Mehlum, Phillips,
Silverman, Takahashi, Hendin.
etine. Media. Strategies for influencing how Analysis and interpretation of data: Mann, Bertolote,
Gatekeeper Education. Where the the media reports suicide need to be Beautrais, Currier, Haas, Hegerl, Malone, Marusic,
Mehlum, Patton, Rutz, Rihmer, Silverman, Hendin.
roles of gatekeepers are formalized and implemented and evaluated. Drafting of the manuscript: Mann, Apter, Beautrais,
pathways to treatment are readily avail- Suicide prevention interventions Currier, Haas, Hegerl, Schmidtke, Shaffer.
Critical revision of the manuscript for important in-
able, such as in the military, educating should be multimodal, evidence- tellectual content: Mann, Apter, Bertolote, Beautrais,
gatekeepers helps reduce suicidal be- based, guided by specific testable Haas, Hegerl, Lonnqvist, Malone, Marusic, Mehlum,
havior. Demonstration projects for other hypotheses, and implemented among Patton, Phillips, Rutz, Rihmer, Schmidtke, Shaffer,
Silverman, Takahashi, Varnik, Wasserman, Yip, Hendin.
gatekeepers with intermediate out- populations of sufficient size to yield Statistical analysis: Mann, Marusic.
come measures, such as referral rates generalizable and reliable results. Pro- Obtained funding: Malone, Hendin.
Administrative, technical, or material support:
and psychiatric treatment rates, should grams must include outcome mea- Beautrais, Currier, Haas, Hegerl, Lonnqvist, Patton,
be conducted. sures. Finally, because most studies Schmidtke, Silverman, Hendin.
Study supervision: Mann, Rutz, Rihmer.
Means Restriction. Restricting ac- have been conducted in developed Financial Disclosures: Dr Mann received a grant from
cess to lethal methods decreases sui- nations, many issues facing underre- GlaxoSmithKline to do a positron-emission tomogra-
phy study of Alzheimer disease; otherwise, no finan-
cides by those methods. Priority should sourced developing nations have not cial disclosures were reported.
be given to the most commonly used been addressed and require future Funding/Support: Funding for the International Strat-
methods in each country. The possibil- studies specifically focused on suicide egies Workshop was provided by an unrestricted edu-
cational grant from Pfizer Inc.
ity of substitution of methods requires prevention. Role of the Sponsor: Pfizer had no role in the design
ongoing monitoring, as does compli- and conduct of the study; collection, management,
Author Affiliations: New York State Psychiatric Insti- analysis, and interpretation of the data; and prepara-
ance with restrictions such as firearm tute, Division of Neuroscience (Drs Mann and Cur- tion, review, or approval of the manuscript.
access. rier) and Division of Child psychiatry (Dr Schaffer), De-
partment of Psychiatry, Columbia University, New
Screening. Although screening pro- York; Department of Psychiatry, Schneiders Chil- REFERENCES
grams have reported some success in drens Medical Center of Israel (Dr Apter); Depart-
ment of Mental Health and Substance Abuse, World 1. World Health Organization. World Health Report
identifying individuals with known risk Health Organization, Geneva, Switzerland (Dr Berto- 2003: Shaping the Future. Geneva, Switzerland: World
factors for suicide, particularly among lote); Canterbury Suicide Project, Christchurch School Health Organization; 2003. Available at: http://www
©2005 American Medical Association. All rights reserved. (Reprinted) JAMA, October 26, 2005—Vol 294, No. 16 2071
.who.int/whr/2003/en/whr03_en.pdf. Accessed Janu- cent suicide prevention programs. Can J Public Health. ness of a quality improvement intervention for ado-
ary 2005. 1996;87:319-324. lescent depression in primary care clinics: a random-
2. World Health Organization. Country reports and 23. Guo B, Harstall C. Efficacy of Suicide Prevention ized controlled trial. JAMA. 2005;293:311-319.
charts Web page. Available at: http://www.who.int Programs for Children and Youth. Edmonton: Al- 43. Orbach I, Bar-Joseph H. The impact of a suicide
/mental_health/prevention/suicide/country_reports berta Heritage Foundation for Medical Research; 2002. prevention program for adolescents on suicidal ten-
/en/index.html. Accessed January 2005. 24. Pignone MP, Gaynes BN, Rushton JL, et al. Screen- dencies, hopelessness, ego identity, and coping. Sui-
3. Centers for Disease Control and Prevention. Na- ing for depression in adults: a summary of the evi- cide Life Threat Behav. 1993;23:120-129.
tional Center for Health Statistics: self-inflicted injury/ dence for the US Preventive Services Task Force. Ann 44. Eggert LL, Thompson EA, Herting JR, Nicholas LJ.
suicide Web page. Available at: http://www.cdc.gov Intern Med. 2002;136:765-776. Reducing suicide potential among high-risk youth: tests
/nchs/fastats/suicide.htm. Accessed January 2005. 25. Feightner J; Canadian Task Force on the Periodic of a school-based prevention program. Suicide Life
4. Kessler RC, Berglund P, Borges G, Nock M, Wang Health Examination. Canadian Guide to Clinical Pre- Threat Behav. 1995;25:276-296.
PS. Trends in suicide ideation, plans, gestures, and at- ventive Health Care. Ottawa, Ontario: Health Canada; 45. Thompson EA, Eggert LL, Randell BP, Pike KC.
tempts in the United States, 1990-1992 to 2001-2003. 1994. Evaluation of indicated suicide risk prevention ap-
JAMA. 2005;293:2487-2495. 26. Gaynes BN, West SL, Ford CA, Frame P, Klein J, proaches for potential high school dropouts. Am J Pub-
5. Goldsmith SK, Pellmar TC, Kleinman AM, Bunney Lohr KN. Screening for suicide risk in adults: a sum- lic Health. 2001;91:742-752.
WE. Reducing Suicide: A National Imperative. Wash- mary of the evidence for the US Preventive Services 46. Huey SJ Jr, Henggeler SW, Rowland MD, et al.
ington, DC: National Academies Press; 2002. Task Force. Ann Intern Med. 2004;140:822-835. Multisystemic therapy effects on attempted suicide by
6. Mann JJ. A current perspective of suicide and at- 27. Gilbody S, Whitty P, Grimshaw J, Thomas R. Edu- youths presenting psychiatric emergencies. J Am Acad
tempted suicide. Ann Intern Med. 2002;136:302-311. cational and organizational interventions to improve Child Adolesc Psychiatry. 2004;43:183-190.
7. Barraclough B, Bunch J, Nelson B, Sainsbury P. One the management of depression in primary care: a sys- 47. Rihmer Z, Belso N, Kalmar S. Antidepressants and
hundred cases of suicide: clinical aspects. Br J tematic review. JAMA. 2003;289:3145-3151. suicide prevention in Hungary. Acta Psychiatr Scand.
Psychiatry. 1974;125:355-373. 28. Hawton K, Townsend E, Arensman E, et al. Psy- 2001;103:238-239.
8. Dorpat TL, Ripley HS. A study of suicide in the Se- chosocial versus pharmacological treatments for de- 48. Marusic A, Roskar S, Dernovsek M, et al. An at-
attle area. Compr Psychiatry. 1960;1:349-359. liberate self harm. Cochrane Database Syst Rev. 2002: tempt of suicide prevention: the Slovene Gotland Study.
9. Rich CL, Fowler RC, Fogarty LA, Young D. San Diego CD001764. In: Program and abstracts of the 10th European Sym-
suicide study, III: relationships between diagnoses and 29. Aseltine RH Jr, DeMartino R. An outcome evalu- posium on Suicide and Suicidal Behavior; August 2004;
stressors. Arch Gen Psychiatry. 1988;45:589-592. ation of the SOS Suicide Prevention Program. Am J Copenhagen, Denmark.
10. Robins E, Murphy GE, Wilkinson RH Jr, Gassner Public Health. 2004;94:446-451. 49. Kelly C. The effects of depression awareness semi-
S, Kayes J. Some clinical considerations in the preven- 30. Thompson C, Kinmonth AL, Stevens L, et al. Ef- nars on general practitioners knowledge of depres-
tion of suicide based on a study of 134 successful fects of a clinical-practice guideline and practice- sive illness. Ulster Med J. 1998;67:33-35.
suicides. Am J Public Health. 1959;49:888-899. based education on detection and outcome of de- 50. Oyama H, Koida J, Sakashita T, Kudo K. Com-
11. Shaffer D, Gould MS, Fisher P, et al. Psychiatric pression in primary care: Hampshire Depression Project munity-based prevention for suicide in elderly by de-
diagnosis in child and adolescent suicide. Arch Gen randomised controlled trial. Lancet. 2000;355:185-191. pression screening and follow-up. Community Ment
Psychiatry. 1996;53:339-348. 31. Bruce ML, Ten Have TR, Reynolds CF III, et al. Health J. 2004;40:249-263.
12. Drake RE, Bartels SJ, Torrey WC. Suicide in schizo- Reducing suicidal ideation and depressive symptoms 51. Mann JJ, Hendin H, Rihmer Z, Kalmar S, Szanto
phrenia: clinical approaches. In: Williams R, Dalby JT, in depressed older primary care patients: a random- J. Depression recognition and suicide prevention pro-
eds. Depression in Schizophrenics. New York, NY: Ple- ized controlled trial. JAMA. 2004;291:1081-1091. gram in the region of Kiskunhalas, Hungary. Avail-
num Press; 1989:171-186. 32. Glick ID, Zaninelli R, Hsu C, et al. Patterns of con- able at: http://www.hu.afsp.org/whats-new/hungary
13. Brent DA, Johnson BA, Perper J, et al. Personal- comitant psychotropic medication use during a 2-year .htm. Accessed January 2005.
ity disorder, personality traits, impulsive violence, and study comparing clozapine and olanzapine for the pre- 52. Knox KL, Litts DA, Talcott GW, Feig JC, Caine ED.
completed suicide in adolescents. J Am Acad Child vention of suicidal behavior. J Clin Psychiatry. 2004; Risk of suicide and related adverse outcomes after ex-
Adolesc Psychiatry. 1994;33:1080-1086. 65:679-685. posure to a suicide prevention programme in the US
14. Phillips MR, Yang G, Zhang Y, Wang L, Ji H, Zhou 33. Meltzer HY, Alphs L, Green AI, et al. Clozapine Air Force: cohort study. BMJ. 2003;327:1376-1378.
M. Risk factors for suicide in China: a national case- treatment for suicidality in schizophrenia: Interna- 53. Motto JA. Newspaper influence on suicide: a con-
control psychological autopsy study. Lancet. 2002;360: tional Suicide Prevention Trial (InterSePT). Arch Gen trolled study. Arch Gen Psychiatry. 1970;23:143-148.
1728-1736. Psychiatry. 2003;60:82-91. 54. Loftin C, McDowall D, Wiersema B, Cottey TJ.
15. Isometsä E, Henriksson M, Marttunen M, et al. 34. Thies-Flechtner K, Muller-Oerlinghausen B, Seib- Effects of restrictive licensing of handguns on homi-
Mental disorders in young and middle aged men who ert W, Walther A, Greil W. Effect of prophylactic treat- cide and suicide in the District of Columbia. N Engl J
commit suicide. BMJ. 1995;310:1366-1367. ment on suicide risk in patients with major affective Med. 1991;325:1615-1620.
16. Bertolote JM, Fleischmann A, De Leo D, Wasser- disorders: data from a randomized prospective trial. 55. Hegerl U, Althaus D, Stefanek J. Public attitudes
man D. Suicide and mental disorders: do we know Pharmacopsychiatry. 1996;29:103-107. towards treatment of depression: effects of an
enough? Br J Psychiatry. 2003;183:382-383. 35. Brown GK, Ten Have TR, Henriques GR, et al. Cog- information campaign. Pharmacopsychiatry. 2003;36:
17. Luoma JB, Martin CE, Pearson JL. Contact with nitive therapy for the prevention of suicide attempts: 288-291.
mental health and primary care providers before sui- a randomized controlled trial. JAMA. 2005;294:563- 56. Jorm AF, Christensen H, Griffiths KM. The im-
cide: a review of the evidence. Am J Psychiatry. 2002; 570. pact of beyondblue: the national depression initia-
159:909-916. 36. Guthrie E, Kapur N, Mackway-Jones K, et al. Ran- tive on the Australian public’s recognition of depres-
18. Andersen UA, Andersen M, Rosholm JU, Gram domised controlled trial of brief psychological inter- sion and beliefs about treatments. Aust N Z J Psychiatry.
LF. Contacts to the health care system prior to sui- vention after deliberate self poisoning. BMJ. 2001;323: 2005;39:248-254.
cide: a comprehensive analysis using registers for gen- 135-138. 57. Paykel ES, Hart D, Priest RG. Changes in public
eral and psychiatric hospital admissions, contacts to 37. Bateman A, Fonagy P. Treatment of borderline attitudes to depression during the Defeat Depression
general practitioners and practicing specialists and drug personality disorder with psychoanalytically oriented Campaign. Br J Psychiatry. 1998;173:519-522.
prescriptions. Acta Psychiatr Scand. 2000;102: partial hospitalization: an 18-month follow-up. Am J 58. Akroyd S, Wyllie J. Impacts of National Media
126-134. Psychiatry. 2001;158:36-42. Campaign to Counter Stigma and Discrimination As-
19. Gunnell D, Saperia J, Ashby D. Selective seroto- 38. Motto JA, Bostrom AG. A randomized con- sociated with Mental Illness: Survey 4. Wellington,
nin reuptake inhibitors (SSRIs) and suicide in adults: trolled trial of postcrisis suicide prevention. Psychiatr New Zealand: New Zealand Ministry of Health; 2002.
meta-analysis of drug company data from placebo con- Serv. 2001;52:828-833. Publication 9-20-0004.
trolled, randomised controlled trials submitted to the 39. Cedereke M, Monti K, Ojehagen A. Telephone 59. Lehfeld H, Althaus DA, Hegerl U, Ziervogel A,
MHRA’s safety review. BMJ. 2005;330:385. contact with patients in the year after a suicide at- Niklewski G. Suicide attempts: results and experi-
20. Fergusson D, Doucette S, Glass KC, et al. Asso- tempt: does it affect treatment attendance and out- ences from the German Competency Network on
ciation between suicide attempts and selective sero- come? a randomised controlled study. Eur Psychiatry. Depression. Adv Psychosom Med. 2004;26:137-143.
tonin reuptake inhibitors: systematic review of ran- 2002;17:82-91. 60. Naismith SL, Hickie IB, Scott EM, Davenport TA.
domised controlled trials. BMJ. 2005;330:396. 40. Allard R, Marshall M, Plante MC. Intensive fol- Effects of mental health training and clinical audit on
21. Khan A, Khan S, Kolts R, Brown WA. Suicide rates low-up does not decrease the risk of repeat suicide general practitioners’ management of common men-
in clinical trials of SSRIs, other antidepressants, and pla- attempts. Suicide Life Threat Behav. 1992;22:303-314. tal disorders. Med J Aust. 2001;175(suppl):S42-S47.
cebo: analysis of FDA reports. Am J Psychiatry. 2003; 41. Morgan HG, Jones EM, Owen JH. Secondary pre- 61. Hannaford PC, Thompson C, Simpson M. Evalu-
160:790-792. vention of non-fatal deliberate self-harm: the green ation of an educational programme to improve the rec-
22. Ploeg J, Ciliska D, Dobbins M, Hayward S, Thomas card study. Br J Psychiatry. 1993;163:111-112. ognition of psychological illness by general practitioners.
H, Underwood J. A systematic overview of adoles- 42. Asarnow JR, Jaycox LH, Duan N, et al. Effective- Br J Gen Pract. 1996;46:333-337.
2072 JAMA, October 26, 2005—Vol 294, No. 16 (Reprinted) ©2005 American Medical Association. All rights reserved.
62. Lin EH, Simon GE, Katzelnick DJ, Pearson SD. Does ticular reference to changes in the pattern of prescrip- in Sweden associated with changes in the prescribing
physician education on depression management im- tions [in Dutch]. Ugeskr Laeger. 1992;154:1972-1976. of medicines? Acta Psychiatr Scand. 1996;94:94-100.
prove treatment in primary care? J Gen Intern Med. 84. Yamasawa K, Nishimukai H, Ohbora Y, Inoue K. 108. Mott JA, Wolfe MI, Alverson CJ, et al. National
2001;16:614-619. A statistical study of suicides through intoxication. Acta vehicle emissions policies and practices and declining
63. Valentini W, Levav I, Kohn R, et al. An educa- Med Leg Soc (Liege). 1980;30:187-192. US carbon monoxide-related mortality. JAMA. 2002;
tional training program for physicians for diagnosis and 85. Hawton K. United Kingdom legislation on pack 288:988-995.
treatment of depression [in Portuguese]. Rev Saude sizes of analgesics: background, rationale, and ef- 109. Kapur S, Mieczkowski T, Mann JJ. Antidepres-
Publica. 2004;38:522-528. fects on suicide and deliberate self-harm. Suicide Life sant medications and the relative risk of suicide at-
64. Pfaff JJ, Acres JG, McKelvey RS. Training general Threat Behav. 2002;32:223-229. tempt and suicide. JAMA. 1992;268:3441-3445.
practitioners to recognise and respond to psychologi- 86. McClure GM. Changes in suicide in England and 110. Wasserman D, Varnik A. Suicide-preventive ef-
cal distress and suicidal ideation in young people. Med Wales, 1960-1997. Br J Psychiatry. 2000;176:64-67. fects of perestroika in the former USSR: the role of
J Aust. 2001;174:222-226. 87. Kelly S, Bunting J. Trends in suicide in England and alcohol restriction. Acta Psychiatr Scand Suppl. 1998;
65. Takahashi K, Naito H, Morita M, Suga R, Oguma Wales, 1982-96. Popul Trends. Summer 1998:29-41. 394:1-4.
T, Koizumi T. Suicide prevention for the elderly in Mat- 88. Shelef M. Unanticipated benefits of automotive 111. Lester D. Effect of changing alcohol laws in Ice-
sunoyama Town, Higashikubiki County, Niigata Pre- emission control: reduction in fatalities by motor land on suicide rates. Psychol Rep. 1999;84(3 pt 2):
fecture: psychiatric care for elderly depression in the vehicle exhaust gas. Sci Total Environ. 1994;146-147: 1158.
community [in Japanese]. Seishin Shinkeigaku Zasshi. 93-101. 112. Phillips B, Ball C, Sackett D, et al. Levels of evi-
1998;100:469-485. 89. Carlsten A, Waern M, Ekedahl A, Ranstam J. An- dence and grades of recommendation Web page. Ox-
66. Rutz W, Von Knorring L, Wálinder J. Frequency tidepressant medication and suicide in Sweden. Phar- ford, England: Oxford Centre for Evidence-Based Medi-
of suicide on Gotland after systematic postgraduate macoepidemiol Drug Saf. 2001;10:525-530. cine; 1998. Available at: http://www.cebm.net
education of general practitioners. Acta Psychiatr 90. Beautrais AL. Effectiveness of barriers at suicide /levels_of_evidence.asp. Accessed July 2005.
Scand. 1989;80:151-154. jumping sites: a case study. Aust N Z J Psychiatry. 2001; 113. Hickie I. Can we reduce the burden of depres-
67. Mehlum L, Schwebs R. Suicide prevention in the 35:557-562. sion? the Australian experience with beyondblue: the
military: recent experiences in the Norwegian army. 91. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The national depression initiative. Australas Psychiatry.
In: Program and abstracts of the 33rd International relationship between antidepressant medication use 2004;12(suppl):S38-S46.
Congress on Military Medicine; June 25-30, 2000; Hel- and rate of suicide. Arch Gen Psychiatry. 2005;65:165- 114. Gould MS, Greenberg T, Velting DM, Shaffer
sinki, Finland. 172. D. Youth suicide risk and preventive interventions: a
68. Dieserud G, Loeb M, Ekeberg O. Suicidal behav- 92. Olfson M, Shaffer D, Marcus SC, Greenberg T. review of the past 10 years. J Am Acad Child Ado-
ior in the municipality of Baerum, Norway: a 12-year Relationship between antidepressant medication treat- lesc Psychiatry. 2003;42:386-405.
prospective study of parasuicide and suicide. Suicide ment and suicide in adolescents. Arch Gen Psychiatry. 115. Burns JM, Patton GC. Preventive interventions
Life Threat Behav. 2000;30:61-73. 2003;60:978-982. for youth suicide: a risk factor-based approach. Aust
69. Aoun S. Deliberate self-harm in rural Western Aus- 93. Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie N Z J Psychiatry. 2000;34:388-407.
tralia: results of an intervention study. Aust N Z J Ment IB, McManus P. Association between antidepressant 116. Hirschfeld RMA, Keller M, Panico S, et al. The
Health Nurs. 1999;8:65-73. prescribing and suicide in Australia, 1991-2000: trend National Depressive and Manic-Depressive Associa-
70. Rotheram-Borus MJ, Piacentini J, Cantwell C, Be- analysis. BMJ. 2003;326:1008. tion consensus statement on the undertreatment of
lin TR, Song J. The 18-month impact of an emer- 94. Helgason T, Tomasson H, Zoega T. Antidepres- depression. JAMA. 1997;277:333-340.
gency room intervention for adolescent female sants and public health in Iceland: time series analysis 117. Goldman LS, Nielsen NH, Champion HC. Aware-
suicide attempters. J Consult Clin Psychol. 2000;68: of national data. Br J Psychiatry. 2004;184:157-162. ness, diagnosis, and treatment of depression. J Gen
1081-1093. 95. Takahashi Y. Amidst a Sharp Increase of Sui- Intern Med. 1999;14:569-580.
71. Etzersdorfer E, Sonneck G. Preventing suicide by cide: Suicide in Japan. Tokyo, Japan: Kokoro no Kagaku 118. Rutz W. Preventing suicide and premature death
influencing mass-media reporting: the Viennese ex- (Nihon Hyoron-sha). 1999;88:2-10. by education and treatment. J Affect Disord. 2001;62:
perience 1980-1996. Arch Suicide Res. 1998;4:67-74. 96. Guaiana G, Andretta M, Corbari L, et al. Antide- 123-129.
72. Bridges FS, Kunselman JC. Gun availability and pressant drug consumption and public health indica- 119. Shaffer D, Scott M, Wilcox H, et al. The Colum-
use of guns for suicide, homicide, and murder in tors in Italy, 1955 to 2000. J Clin Psychiatry. 2005;66: bia Suicide Screen: validity and reliability of a screen
Canada. Percept Mot Skills. 2004;98:594-598. 750-755. for youth suicide and depression. J Am Acad Child Ado-
73. Lester D, Leenaars A. Suicide rates in Canada be- 97. Simon GE, Savarino J, Operskalski B, Wang PS. lesc Psychiatry. 2004;43:71-79.
fore and after tightening firearm control laws. Psy- Suicide risk during antidepressant treatment. Am J 120. Cauffman E. A statewide screening of mental
chol Rep. 1993;72:787-790. Psychiatry. In press. health symptoms among juvenile offenders in
74. Snowdon J, Harris L. Firearms suicides in Australia. 98. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen detention. J Am Acad Child Adolesc Psychiatry. 2004;
Med J Aust. 1992;156:79-83. RR. Antidepressant treatment and risk of suicide at- 43:430-439.
75. Ludwig J, Cook PJ. Homicide and suicide rates as- tempt by adolescents with major depressive disor- 121. Joiner TE Jr, Pfaff JJ, Acres JG. A brief screening
sociated with implementation of the Brady Handgun der: a propensity-adjusted retrospective cohort study. tool for suicidal symptoms in adolescents and young
Violence Prevention Act. JAMA. 2000;284:585-591. CNS Drugs. 2004;18:1119-1132. adults in general health settings: reliability and valid-
76. Ohberg A, Lonnqvist J, Sarna S, Vuori E, Penttila 99. Ludwig J, Marcotte DE. Anti-depressants, sui- ity data from the Australian National General Prac-
A. Trends and availability of suicide methods in Fin- cide, and drug regulation. J Policy Anal Manage. 2005; tice Youth Suicide Prevention Project. Behav Res Ther.
land: proposals for restrictive measures. Br J Psychiatry. 24:249-272. 2002;40:471-481.
1995;166:35-43. 100. Cantor CH, Slater PJ. The impact of firearm con- 122. Scott M, Shaffer D, Wilcox H. The Columbia sui-
77. Bowles J. Suicide in Western Samoa: an example trol legislation on suicide in Queensland: preliminary cide screen: does screening identify new teens at risk?
of a suicide prevention program in a developing findings. Med J Aust. 1995;162:583-585. Presented at the American Academy of Child and Ado-
country. In: Diekstra R, Gulbinat R, De Leo D, Kien- 101. Whitlock FA. Suicide in Brisbane, 1956 to 1973: lescent Psychiatry; October 21, 2004; Washington, DC.
horst I, eds. Preventive Strategies on Suicide. Leiden, the drug-death epidemic. Med J Aust. 1975;1:737-743. 123. Gould MS, Marrocco FA, Kleinman M, et al.
the Netherlands: Brill; 1995. 102. Lester D. Effects of detoxification of domestic Evaluating iatrogenic risk of youth suicide screening
78. Carrington PJ. Gender, gun control, suicide and gas on suicide in the Netherlands. Psychol Rep. 1991; programs: a randomized controlled trial. JAMA. 2005;
homicide in Canada. Arch Suicide Res. 1999;5:71-75. 68:202. 293:1635-1643.
79. Kreitman N. The coal gas story: United Kingdom 103. Wiedenmann A, Weyerer S. The impact of avail- 124. Henriksson S, Boethius G, Isacsson G. Suicides
suicide rates, 1960-71. Br J Prev Soc Med. 1976;30: ability, attraction and lethality of suicide methods on are seldom prescribed antidepressants: findings from
86-93. suicide rates in Germany. Acta Psychiatr Scand. 1993; a prospective prescription database in Jamtland county,
80. Lester D. The effect of the detoxification of do- 88:364-368. Sweden, 1985-95. Acta Psychiatr Scand. 2001;103:
mestic gas in Switzerland on the suicide rate. Acta Psy- 104. Lester D. The effects of detoxification of do- 301-306.
chiatr Scand. 1990;82:383-384. mestic gas on suicide in the United States. Am J Pub- 125. Lonnqvist JK, Henriksson MM, Isometsa ET, et al.
81. Gunnell D, Middleton N, Frankel S. Method avail- lic Health. 1990;80:80-81. Mental disorders and suicide prevention. Psychiatry
ability and the prevention of suicide: a re-analysis of 105. Oliver RG, Hetzel BS. Rise and fall of suicide rates Clin Neurosci. 1995;49(suppl 1):S111-S116.
secular trends in England and Wales 1950-1975. Soc in Australia: relation to sedative availability. Med J Aust. 126. Coyle JT, Pine DS, Charney DS, et al. Depres-
Psychiatry Psychiatr Epidemiol. 2000;35:437-443. 1972;2:919-923. sion and bipolar support alliance consensus state-
82. Crome P. The toxicity of drugs used for suicide. 106. Retterstol N. Norwegian data on death due to ment on the unmet needs in diagnosis and treatment
Acta Psychiatr Scand Suppl. 1993;371:33-37. overdose of antidepressants. Acta Psychiatr Scand. of mood disorders in children and adolescents. J Am
83. Nielsen AS, Nielsen B. Pattern of choice in prepa- 1989;80(suppl 354):61-68. Acad Child Adolesc Psychiatry. 2003;42:1494-1503.
ration of attempted suicide by poisoning with par- 107. Carlsten A, Allebeck P, Brandt L. Are suicide rates 127. Oquendo MA, Kamali M, Ellis SP, et al. Adequacy
©2005 American Medical Association. All rights reserved. (Reprinted) JAMA, October 26, 2005—Vol 294, No. 16 2073
of antidepressant treatment after discharge and the oc- spective study of clinical predictors of suicidal acts af- tients with subthreshold depression benefit in the long
currence of suicidal acts in major depression: a prospec- ter a major depressive episode in patients with major run? Am J Psychiatry. 2005;162:1149-1157.
tive study. Am J Psychiatry. 2002;159:1746-1751. depressive disorder or bipolar disorder. Am J Psychiatry. 140. Hansen V, Jacobsen BK, Arnesen E. Cause-specific
128. Agency for Health Care Policy and Research. Evi- 2004;161:1433-1441. mortality in psychiatric patients after deinstitutionalisation.
dence Report on Treatment of Depression: Newer 134. Angst F, Stassen HH, Clayton PJ, Angst J. Mor- Br J Psychiatry. 2001;179:438-443.
Pharmacotherapies. Washington, DC: AHCPR Evi- tality of patients with mood disorders: follow-up over 141. Pirkis J, Blood RW. Suicide and the media, I: re-
dence-Based Practice Centers; 1999. 34-38 years. J Affect Disord. 2002;68:167-181. portage in nonfictional media. Crisis. 2001;22:146-154.
129. Malone KM, Szanto K, Corbitt EM, Mann JJ. Clini- 135. Goldacre M, Seagroatt V, Hawton K. Suicide af- 142. Pirkis J, Blood RW. Suicide and the media, II: por-
cal assessment versus research methods in the assess- ter discharge from psychiatric inpatient care. Lancet. trayal in fictional media. Crisis. 2001;22:155-162.
ment of suicidal behavior. Am J Psychiatry. 1995;152: 1993;342:283-286. 143. Gould MS. Suicide and the media. Ann N Y Acad
1601-1607. 136. Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Sci. 2001;932:200-221.
130. Leon AC, Marzuk PM, Tardiff K, Teres JJ. Par- Mann JJ. Inadequacy of antidepressant treatment 144. Michel K, Frey C, Wyss K, Valach L. An exer-
oxetine, other antidepressants, and youth suicide in for patients with major depression who are at risk for cise in improving suicide reporting in print media. Crisis.
New York City: 1993 through 1998. J Clin Psychiatry. suicidal behavior. Am J Psychiatry. 1999;156: 2000;21:71-79.
2004;65:915-918. 190-194. 145. American Foundation for Suicide Prevention. Re-
131. Keller MB, Lavori PW, Rice J, Coryell W, 137. Katon W, Von Korff M, Lin E, et al. Collabora- porting on suicide: recommendations for the media.
Hirschfeld RM. The persistent risk of chronicity in tive management to achieve treatment guidelines: im- Available at: http://www.afsp.org/index-1.html. 2002.
recurrent episodes of nonbipolar major depressive pact on depression in primary care. JAMA. 1995;273: Accessed July 2005.
disorder: a prospective follow-up. Am J Psychiatry. 1026-1031. 146. O’Carroll PW, Potter LB. Suicide contagion and
1986;143:24-28. 138. Katon W, Robinson P, Von Korff M, et al. A mul- the reporting of suicide: recommendations from a na-
132. Vergouwen AC, Bakker A, Katon WJ, Verheij TJ, tifaceted intervention to improve treatment of de- tional workshop. MMWR Recomm Rep. 1994;
Koerselman F. Improving adherence to antidepres- pression in primary care. Arch Gen Psychiatry. 1996; 43(RR-6):9-17.
sants: a systematic review of interventions. J Clin 53:924-932. 147. Bridges FS. Gun control law (Bill C-17), suicide,
Psychiatry. 2003;64:1415-1420. 139. Wells K, Sherbourne C, Duan N, et al. Quality and homicide in Canada. Psychol Rep. 2004;94:819-
133. Oquendo MA, Galfalvy H, Russo S, et al. Pro- improvement for depression in primary care: do pa- 826.
2074 JAMA, October 26, 2005—Vol 294, No. 16 (Reprinted) ©2005 American Medical Association. All rights reserved.